| Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932) |
|---|
| 09/19/2006 | US7109329 Side effect reduction; muscular disorders; trauma |
| 09/19/2006 | CA2240845C New barbituric acid derivatives, processes for their production and pharmaceutical agents containing these compounds |
| 09/14/2006 | WO2006078593A3 Direct compression formulation and process |
| 09/14/2006 | US20060205943 Process for preparing xanthine phosphodiesterase V inhibitors and precursers thereof |
| 09/14/2006 | US20060205942 2-(2-Hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors |
| 09/14/2006 | US20060205750 Cardiovascular disorders; central nervous system disorders; metabolic diseases; therapy for eating disorders; trans-2-(2-fluorophenyl)-8-[3'-oxospiro[cyclohexane-1,1'(3'H)-isobenzofuran]-4-yl]purine |
| 09/14/2006 | US20060205745 Microcrystal |
| 09/14/2006 | US20060205711 Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions |
| 09/14/2006 | US20060205686 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
| 09/13/2006 | EP1699800A2 Bicyclic heterocyclic p-38 kinase inhibitors |
| 09/12/2006 | US7105667 Fused heterocyclic compounds and use thereof |
| 09/12/2006 | US7105666 Synthesis of purine derivatives |
| 09/12/2006 | US7105665 Compound for treatment of diarrhea, nervous system disorders such as Alzheimers and asthma in mammals |
| 09/12/2006 | US7105526 Benzimidazole derivatives |
| 09/12/2006 | CA2246164C Process for preparing ganciclovir derivatives |
| 09/08/2006 | WO2006093041A1 Novel crystals of n-benzyl-n-ethyl-2-(7-methyl-8-oxo-2-phenyl-7,8-dihydro-9h-purin-9-yl)acetoamide |
| 09/07/2006 | US20060199953 Thionucleoside s-nitrosyl derivative |
| 09/06/2006 | EP1698627A1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/06/2006 | EP1697394A2 Comt inhibitors |
| 09/06/2006 | EP1697363A2 Purine compounds which can be used as phosphodiesterase (pde) type iv inhibitors |
| 09/06/2006 | EP1697292A1 Method for the production of tetrahydrogeranylacetone |
| 09/06/2006 | CN1829718A Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 09/05/2006 | US7102018 Such as 2-(t-butyldimethylsilyloxymethyl)-3,4-((dimethylmethylene)-dioxy)-5-hydroxy -tricyclo(5.2.1.02,6)deca -3,8-diene; for Diels-alder reaction; antitumor agents |
| 08/31/2006 | WO2006091936A2 Methods for the synthesis of unsymmetrical cycloalkyl substituted xanthines |
| 08/31/2006 | WO2006091905A1 Bicyclo (3.1.0) hexane derivatives as antiviral compounds |
| 08/31/2006 | WO2005120577A3 Derivatives of chemotherapeutic agents with a formaldehyde releasing moeity |
| 08/31/2006 | WO2004087053A3 Dipeptidyl peptidase inhibitors |
| 08/31/2006 | US20060194817 N-{(1S,2R)-1-(3,5-difluorobonzyl)-2-hydroxy-3-[(3-iodobonzyl)amino]propyl}-2-{4-[(methylsulfonyl)amino]phenyl}acetamide; inhibitors of the beta- secretase enzyme useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mamma |
| 08/30/2006 | EP1421198A4 Cell-based high-throughput screening methods |
| 08/30/2006 | CN1823626A Theobromine having carcinogenesis suppressing function |
| 08/29/2006 | US7098330 Pyrazolylamine substituted quinazoline compounds useful as protein kinase inhibitors |
| 08/29/2006 | US7098197 An antiviral nucleoside in which the 5'-hydroxyl group has been substituted for a phosphonate or methyl phosphonate that is covalently linked to an alkylethanediol; osteoporosis; anticarcinogenic agents; viricides |
| 08/24/2006 | WO2006087538A1 Chemical compounds |
| 08/24/2006 | US20060189681 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same |
| 08/24/2006 | US20060189636 Inhibitors of E1 activating enzymes |
| 08/24/2006 | CA2598076A1 Chemical compounds |
| 08/23/2006 | EP1693373A1 Enantiomerically pure beta-D-(-)-dioxolane-nucleosides |
| 08/23/2006 | EP1692134A2 A valacyclovir impurity, process for the preparation of valacyclovir impurity and use as a reference standard |
| 08/23/2006 | EP1691813A2 Ready-for-use injectable solution of 9-((1,3-dihydroxypropan-2-iloxy)methyl)-2-amine-1h-purin-6(9h)-one, sterile, stable; closed system for packing the solution, process for eliminating alkaline residuals of 9-((1,3-dihydroxypropan-2-iloxy)methyl)-2-amine-1h-purin-6(9h)-one crystals; pharmaceutical |
| 08/23/2006 | EP1401836B1 Imidazo¬1,2-a|pyridine derivatives for the prophylaxis and treatment of herpes viral infections |
| 08/23/2006 | CN1822842A Solid pharmaceutical preparation |
| 08/23/2006 | CN1271070C Derivatives of triazolyl-imidazopyridine and of the triazolylpurines useful as ligands of the adenosine A2a receptor and their use as medicaments |
| 08/22/2006 | US7094772 Phosphonate compounds |
| 08/17/2006 | WO2006085219A2 6-ether/thioether-purines as topoisomerase ii catalytic inhibitors and their use in therapy |
| 08/17/2006 | WO2005097140A3 Selective antagonists of a2a adenosine receptors |
| 08/17/2006 | WO2005084401A3 Aryl substituted purine analogues |
| 08/17/2006 | US20060183783 2-[3-(2-cyclopentanecarbonyl-4-methyl-phenyl)-ureido]-thiazol-4-yl} acetic acid; 2-[3-(4-Methyl-2-[2-methylpropoxy] phenyl)-ureido]-thiazol-4-yl}-acetic acid; activators of glucokinase; treatment of metabolic disorders, hyperglycemic agent, syndrome x, anticholesterol, hypertension etc. |
| 08/17/2006 | US20060183760 (2S3R)-3-{9-Isopropyl-6-[(pyridin-2-ylmethyl)-amino]-9H-purin-2-ylamino}-pentan-2-ol; treating proliferative disorders, viral disorders, CNS disorders, diabetes, stroke, alopecia or neurodegenerative; cancer, leukemia, psoriasis; cyclin-dependent kinase (CDK) inhibitors |
| 08/17/2006 | CA2596422A1 6-ether/thioether-purines as topoisomerase ii catalytic inhibitors and their use in therapy |
| 08/16/2006 | EP1690864A2 Tricyclic purine compounds and their analogs as inhibitors of cytokine signalling |
| 08/16/2006 | EP1689748A1 Novel 8-(piperazine-1-yl)- and 8-( 1,4|diazepan-1-yl)-xanthine, the production and use thereof in the from of a drug |
| 08/16/2006 | EP1509525B1 Process for preparing xanthine phosphodiesterase v inhibitors and precursors thereof |
| 08/16/2006 | EP1252160B1 Methanocarba cycloalkyl nucleoside analogues |
| 08/15/2006 | US7091346 Purine derivatives and processes for their preparation |
| 08/15/2006 | CA2243650C Process for preparing purine derivatives |
| 08/15/2006 | CA2230808C A novel purine derivative |
| 08/10/2006 | WO2006084281A1 Inhibitors of e1 activating enzymes |
| 08/10/2006 | WO2006083832A1 Method for preparing amino acid esters of nucleoside analogues |
| 08/10/2006 | US20060178379 Methods of treating patients suffering from movement disorders |
| 08/10/2006 | US20060178345 Substituted alcohols useful in treatment of Alzheimer's disease |
| 08/10/2006 | CA2596424A1 Inhibitors of e1 activating enzymes |
| 08/10/2006 | CA2596368A1 Diketo acids with nucleobase scaffolds: anti-hiv replication inhibitors targeted at hiv integrase |
| 08/09/2006 | EP1687306A1 Bicyclic pyrimidin-4-(3h)-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1 receptor (vr1) |
| 08/09/2006 | EP1551838B1 Method for reducing residual alcohols in crystalline valacyclovir hydrochloride |
| 08/09/2006 | CN1814596A Muscarinic agonists |
| 08/08/2006 | US7087614 Pyrimidine inhibitors of phosphodiesterase (PDE) 7 |
| 08/08/2006 | US7087603 Pyrazole compounds useful as protein kinase inhibitors |
| 08/08/2006 | US7087589 Chemically modified adenine or uracil bounded to a cyclopentyl group derivatized with a cyclopropane bridge, and such compound binds a receptor |
| 08/08/2006 | CA2282183C Oxy substituted 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines |
| 08/08/2006 | CA2207258C Xanthine compounds having terminally aminated alkynol side chains |
| 08/03/2006 | WO2006079731A2 Use of cacao polyphenols for treating a prostate hyperplasia, a specific cacao extract and applications |
| 08/03/2006 | US20060173181 8-Quinolinxanthine and 8-isoquinolinxanthine derivatives as PDE 5 inhibitors |
| 08/02/2006 | EP1685132A1 A sb 2B /sb ADENOSINE RECEPTOR ANTAGONISTS |
| 08/02/2006 | EP1685127A1 Heterocyclyl-substituted oxetanes for the treatment of proliferative or infectious diseases |
| 08/02/2006 | EP1684762A2 Urea derivatives as kinase modulators |
| 08/02/2006 | EP1430050B1 Piperidine derivatives and their use as modulators of chemokine (especially ccr3) activity |
| 08/02/2006 | CN1812990A Process for the preparation of famciclovir |
| 08/02/2006 | CN1267446C Nucleoside derivatives as inhibitors of RNA-dependent PNA viral polymerase |
| 08/01/2006 | CA2341263C Enzyme inhibition immunoassay |
| 08/01/2006 | CA2198701C Substituted 9-alkyladenines |
| 07/27/2006 | US20060167252 Imidazo[1,2-a]pyridine derivatives for treatment of herpes viral infections |
| 07/27/2006 | US20060167224 Novel functional peptide nucleic acid and process for producing the same |
| 07/27/2006 | US20060166999 Use of microsomal triglyceride transfer protein (MTP) inhibitors for reducing the number of postprandial triglyceride-rich lipoprotein particles (PPTRL) |
| 07/27/2006 | US20060166925 Substitution derivatives of n6-benzyladenosine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds |
| 07/27/2006 | CA2593359A1 Direct compression formulation and process |
| 07/26/2006 | EP1683056A2 Method for identifying inhibitors using a homology model of polo-like kinase 1 |
| 07/26/2006 | EP1682150A2 Compositions and methods for inducing cell dedifferentiation |
| 07/26/2006 | CN1266112C Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 07/25/2006 | US7081466 anticarcinogenic agents with improved efficacy against multidrug resistant tumors; improved oral bioavailability and side effect reduction |
| 07/25/2006 | CA2182105C Chloropyrimide intermediates |
| 07/20/2006 | WO2006076595A1 Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith |
| 07/20/2006 | WO2006075094A2 Purine derivatives compositions containing the same and use thereof against cancer |
| 07/20/2006 | WO2006074985A1 5-membered annelated heterocyclic pyrimidines as kinase inhibitors |
| 07/20/2006 | WO2006074925A1 Purine derivatives acting as a2a receptor agonists |
| 07/20/2006 | US20060160819 Substitued piperazine carbamates |
| 07/20/2006 | US20060160123 For increasing stability of short interfering RNA molecule when in contact with biological sample, and reducing off-target effects/interferon responsiveness; ribonuclease stability |
| 07/20/2006 | CA2594425A1 5-membered annelated heterocyclic pyrimidines as kinase inhibitors |
| 07/20/2006 | CA2593398A1 Purine derivatives acting as a2a receptor agonists |
| 07/19/2006 | CN1805962A Inosine derivatives and production methods therefor |
| 07/19/2006 | CN1803810A Antiviral agents and preparing method thereof |